Antibody-Redirected Effector Lymphocytes Extend Sensitivity in Preclinical Breast Cancer Models
In preclinical breast cancer models, cytokine-induced killer cells redirected with engineered HER2 antibodies enhanced cytotoxicity and broadened therapeutic sensitivity across ...

